Contact SCGE




SCGE Consortium Home   |  About SCGE Toolkit   |  Contact Us   |  Citing the Toolkit   |  License  
ExperimentShuttle peptides enable in vivo gene editing with Cas9 and Cas12a RNP in mouse airway epithelia
Experiment ConditionS10, Cas12a
Assay Description: Quantitation of GFP+ cells in large and small airways following 1 delivery of GFP protein by GFP positive cells compared to DAPI stained cells.
Tissue Measured:epithelium of bronchiole
Measurement Type:Editing Efficiency
Record ID15000000279

EditorAsCas12a (IDT and Feldan Therapeutics)
Delivery SystemS10
Delivery System SubtypeAmphiphilic peptide
Guideg-loxPbot_C12a
Vector

Model SpeciesMouse
Model NameGt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo

Application Methodnasal instillation
Application Siteairway epithelium
Dosage [S10]: 40 µM; [Cas12a): 2.5 µM; [gRNA]: 2 µM
Injection Frequencytwice
Injection Ratedaily for 2 consecutive days
Injection Volume50 ul
Days post injection7 days
Editor FormatRNP
Antidote Id
Antidote Descriptioncilia (α-tubulin); nuclei (DAPI)

Measured Values
Samples Size: 3
 
Replicate Result (Editing Efficiency)
Measurement Units: % of cells
Mean 9.90 
1 7.2 
2 10.7 
3 11.8 
  

Publication Title
Engineered amphiphilic peptides enable delivery of proteins and CRISPR-associated nucleases to airway epithelia. NCBI